当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:24.70亿  总市值:24.74亿
流通股本:4.99亿   总股本:5.00亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.25亿元,每股收益-0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益146203.18万元,未分配利润-45478.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产237118.42万元,负债90915.24万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入234,594,741.641,138,365,803846,178,408.68557,454,592.06
营业总成本263,463,408.411,211,647,999.03889,616,101.73581,638,146.1
营业利润-27,268,564.97-927,553,721.9-34,688,682.63-18,517,565.47
利润总额-27,440,132.91-930,955,940.3-34,435,257.87-18,353,905.53
净利润-25,499,750.88-908,128,966.44-41,349,450.65-21,845,264.96
其他综合收益1,875,939.77,823,267.3910,001,858.319,785,819.93
综合收益总额-23,623,811.18-900,305,699.05-31,347,592.34-12,059,445.03
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计676,526,244.27727,179,070.94813,578,908.14805,512,958.31
非流动资产合计1,694,657,918.871,731,913,859.182,597,545,355.592,625,252,998.64
资产总计2,371,184,163.142,459,092,930.123,411,124,263.733,430,765,956.95
流动负债合计384,931,622.86426,774,745.76503,310,150.71489,897,105.59
非流动负债合计524,220,743.46546,662,576.36553,200,398.3566,966,989.34
负债合计909,152,366.32973,437,322.121,056,510,549.011,056,864,094.93
归属于母公司股东权益合计1,437,831,988.91,461,416,599.862,330,334,092.842,349,545,914.8
股东权益合计1,462,031,796.821,485,655,6082,354,613,714.722,373,901,862.02
负债和股东权益合计2,371,184,163.142,459,092,930.123,411,124,263.733,430,765,956.95
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计267,606,773.941,313,071,840.01981,054,368.36641,521,266.91
经营活动现金流出小计242,373,085.641,162,079,525.18894,248,457.38633,964,378.2
经营活动产生的现金流量净额25,233,688.3150,992,314.8386,805,910.987,556,888.71
投资活动现金流入小计2,511,697.69587,849,982.78512,014,055.38481,708,694.58
投资活动现金流出小计35,216,989.54600,670,352.45543,930,761.02499,665,535.05
投资活动产生的现金流量净额-32,705,291.85-12,820,369.67-31,916,705.64-17,956,840.47
筹资活动现金流入小计-107,954,916107,063,90083,055,000
筹资活动现金流出小计11,828,622.33496,296,231.4463,965,286.1404,379,295.94
筹资活动产生的现金流量净额-11,828,622.33-388,341,315.4-356,901,386.1-321,324,295.94
汇率变动对现金及现金等价物的影响3,073,804.446,975,104.056,667,811.755,412,090.16
现金及现金等价物净增加额-16,226,421.44-243,194,266.19-295,344,369.01-326,312,157.54
期末现金及现金等价物余额326,002,953.77342,229,375.21290,079,272.39259,111,483.86
TOP↑